QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine 期刊论文 BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 112 作者:   收藏  |  浏览/下载：36/0  |  提交时间：2019/11/19 Doxorubicin  Curcumin  Lung cancer  pH sensitive  Urokinase plasminogen activator receptor   Structural determination of group A Streptococcal surface dehydrogenase and characterization of its interaction with urokinase-type plasminogen activator receptor 期刊论文 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 卷号: 510, 页码: 539-544 作者:  Li, Rui;  Liang, Chenghui;  Jiang, Longguang;  Yuan, Cai;  Huang, Mingdong 收藏  |  浏览/下载：2/0  |  提交时间：2019/11/21 Group A Streptococcus  Interaction  Crystal structure  Streptococcal surface dehydrogenase  Urokinase-type plasminogen activator receptor   Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release 期刊论文 THERANOSTICS, 2019, 卷号: 9, 页码: 884-899 作者:  Li, Shijie;  Yuan, Cai;  Chen, Jincan;  Chen, Dan;  Chen, Zhuo 收藏  |  浏览/下载：12/0  |  提交时间：2019/11/21 amino terminal fragment of urokinase-type plasminogen activator  urokinase receptor  human serum albumin  cargo release  receptor-triggered disintegration   Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release. 期刊论文 Theranostics, 2019, 卷号: No.3, 页码: 884-899 作者:  Shijie Li;  Cai Yuan;  Jincan Chen;  Dan Chen;  Zhuo Chen 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/13 amino terminal fragment of urokinase-type plasminogen activator  cargo release  human serum albumin  receptor-triggered disintegration  urokinase receptor   Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease 期刊论文 Archives of Medical Research, 2019, 卷号: 50, 期号: 5, 页码: 249-256 作者:  Zhou Y.;  Ren J.;  Li P.;  Ma R.;  Zhou M. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 Diabetic kidney disease  Soluble urokinase-type plasminogen activator receptor  Type 2 diabetes mellitus  Urokinase-type plasminogen activator receptor   Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms 期刊论文 2019, 卷号: 13, 期号: 2, 页码: 180-189 作者:  Jin, Ye;  Liang, Zhi-Yong;  Zhou, Wei-Xun;  Zhou, Li 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03 Hepatocellular carcinoma  Plasminogen activator inhibitor 2  Urokinase-type plasminogen activator  RB  E2F1  Prognosis